What is the main business of Shiraz Productions?

The main business activity of Shiraz Productions focuses on manufacture of pharmaceutical preparations.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on September 23, 2021.

Where is the headquarters located?

The headquarters is located at: ul. Tymiankowa 24, 95-054 Ksawerów.

What is the share capital?

The share capital of the company is PLN 7,000 (approx. $1,891).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2023 to December 31, 2023.

How much revenue was generated?

The company reported a revenue of $50,774 in 2023, which is an increase of 16.9% compared to 2022.

Is the company profitable?

No, the company recorded a net loss of $15,244 in 2023. For comparison, in 2022 the loss was $41,795, meaning the company reduced its loss by 65.6%.

What is the main operating cost?

The largest operating cost category falls under external services. This category amounted to $26,657 in 2023, representing 58% of all operating expenses.

Shiraz Productionssp. z o.o.

Manufacture of pharmaceutical preparations

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2021-09-23

Share capital

7,000.00 PLN

Activity description

Shiraz Productions Sp. z o.o. repackages medical devices and dietary supplements. It also repackages medicinal products containing psychotropic substances in groups II-P, III-P and IV-P, and narcotic substances in groups I-N, II-N and III-N.

Registered address

ul. Tymiankowa 24/28, 95-054 Ksawerów, Poland

Website

shirazproductions.pl

Phone

Electronic delivery address

AE:PL-72665-78000-ADRIC-10

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2024 – the filing deadline has passed. 2 of 2 financial statements were filed late (the longest delay 45 days for 2022).

2024not filed
202316/07/2024
202229/08/2023

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2023.

Results vs industry

Revenue

This companyUSD 50.77kMedianUSD 917.74kAverageUSD 25.73m

Net profit

This companyUSD -15.24kMedianUSD 14.44kAverageUSD 2.75m

Operating costs

This companyUSD 45.93kMedianUSD 860.03kAverageUSD 21.34m

Assets

This companyUSD 41.46kMedianUSD 883.09kAverageUSD 31.39m

Industry

Offer

Repackaging of medical devices
Repackaging of dietary supplements
Repackaging of medicinal products

Website technology

Website

WordPress

Authorized Representatives

Grzegorz Pogorzelski – Vice President of the Management Board

Łukasz Widarski – Vice President of the Management Board

Marek Roland Wasiluk – Vice President of the Management Board

Manner of representation

In the case of a one-person management board, the sole member of the management board acting independently is authorized to represent the company. In the case of a multi-member management board, two members of the management board acting jointly are authorized to represent the company.

Ownership

Owner	Shares	Share value	Stake
Bogdan Bartkiewiczage 63	58	$783.36	41.4286%
Maciej Jabłońskiage 48	7	$94.54	5%
Marek Roland Wasilukage 52	42	$567.26	30%
Łukasz Widarskiage 45	33	$445.71	23.5714%

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 2021-12-09.

ING Bank Śląski
69 1050 1908 1000 0090 8207 9030

Debt

No entries in the National Debtors Register (KRZ).

MSiG notices

Publication date	Event
May 17, 2022	Commercial Companies Code notice

Public aid

No public aid cases recorded in the last 10 years.

Regulatory authorisations

Authority	Type	Status
BDO	BDO register entry	Active

Competitors

Name	Revenue	Website
Pexon Polandsp. z o.o.	$122,615.96	pexon.pl
Meta Pharmaceutical Productionsp. z o.o.	$41,273.73	metapharmaceutical.pl
Quantum Biomedsp. z o.o.	$13,877.54	quantum-biomed.pl

Change history

Date	Event
2023-08-23	PKD change (Removed: 70.22.Z, 74.90.Z, 85.59.B; Added: 72.11.Z, 73.1)
2022-02-01	Share capital increase (5,000.00 PLN → 7,000.00 PLN)
2021-09-23	Entered in the register

FAQ

Last updated: 2026-03-27